HLYK — HealthLynked Share Price
0.000.00%
Last trade - 00:00- $14.28m
- $15.07m
- $5.72m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 17.8 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.5 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -230.03% | ||
| Return on Equity | -649.01% | ||
| Operating Margin | -75.09% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4.02 | 6.13 | 6.5 | 5.86 | 5.72 | n/a | n/a | 20.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HealthLynked Corp. operates through three division: the Health Services Division, the Digital Healthcare Division, and the Medical Distribution Division. The Health Services division is comprised of the operations of Naples Womens Center (NWC), a medical group including (both obstetrics and gynecology) and general practice; Naples Center for Functional Medicine (NCFM), a functional medical practice engaged in improving the health of its patients through individualized and integrative health care; Bridging the Gap Physical Therapy (BTG), and Aesthetic Enhancements Unlimited (AEU). The Digital Healthcare division develops and operates an online personal medical information and record archive system, the HealthLynked Network. The Medical Distribution Division is comprised of the operations of MedOffice Direct LLC (MOD), a virtual distributor of discounted medical supplies selling to both consumers and medical practices throughout the United States.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 6th, 2014
- Public Since
- May 3rd, 2017
- No. of Shareholders
- 305
- No. of Employees
- 38
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 281,064,958
- Address
- 1265 CREEKSIDE PARKWAY, SUITE 302, NAPLES, 34108
- Web
- https://www.healthlynked.com/
- Phone
- Auditors
- RBSM LLP
Upcoming Events for HLYK
Q2 2024 Healthlynked Corp Earnings Release
Similar to HLYK
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
What is the HealthLynked share price?
As of Today at 19:10 UTC, shares in HealthLynked are trading at $0.05. This share price information is delayed by 15 minutes.
How has the HealthLynked share price performed this year?
Shares in HealthLynked last closed at $0.05 and the price had moved by -29.44% over the past 365 days. In terms of relative price strength the HealthLynked share price has underperformed the S&P500 Index by -37.75% over the past year.
What are the analyst and broker recommendations for HealthLynked?
There is no consensus recommendation for this security.
What is the HealthLynked dividend yield?
HealthLynked does not currently pay a dividend.
Does HealthLynked pay a dividend?
HealthLynked does not currently pay a dividend.
When does HealthLynked next pay dividends?
HealthLynked does not currently pay a dividend.
How do I buy HealthLynked shares?
To buy shares in HealthLynked you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HealthLynked?
As of the previous close price of $0.05, shares in HealthLynked had a market capitalisation of $14.28m.
Where are HealthLynked shares listed?
Here are the trading details for HealthLynked:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HLYK
What kind of share is HealthLynked?
Based on an overall assessment of its quality, value and momentum HealthLynked is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HealthLynked share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the HealthLynked share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HealthLynked. Over the past six months, its share price has underperformed the S&P500 Index by -27.01%.
As of the last closing price of $0.05, shares in HealthLynked were trading -13.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HealthLynked PE Ratio?
The HealthLynked PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HealthLynked?
We do not have data on HealthLynked's directors